Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry
NonrulemakingOtherFDA-2025-D-1504-0002
Comments
36
Awaiting comments
Deadline
Closed on May 9, 2026
Closed May 9, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Mar 9, 2026
- Comment period
- Mar 9, 2026 – May 9, 2026
- Agency
- Food and Drug Administration (FDA)
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Analyzed 0 of 36 comments
0%· analysis in progress
Stance breakdown
—
Net support
Who commented
Breakdown by commenter type, organic comments only.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.